In-vivo near-infrared optical imaging of growing osteosarcoma cell lesions xenografted in mice: Dual-channel quantitative evaluation of volume and mineralization

Acta Radiologica

Volumn 52, Issue 9, 2011, Pages 978-988

  Nakayama, Hitoshi ^a,b   Kawase, Tomoyuki ^a   Okuda, Kazuhiro ^a   Wolff, Larry F ^c   Yoshie, Hiromasa ^a  

^a NIIGATA UNIVERSITY   (Japan)

^b JAPAN SCIENCE AND TECHNOLOGY AGENCY   (Japan)

^c UNIVERSITY OF MINNESOTA   (United States)

Author keywords

2 deoxyglucose; Mineralization; Near infrared; Optical imaging; Osteosarcoma; Pamidronate

Indexed keywords

2-DEOXYGLUCOSE; MINERALIZATION; NEAR INFRARED; OPTICAL IMAGING; OSTEOSARCOMA; PAMIDRONATE;

COMPUTERIZED TOMOGRAPHY; MAMMALS; MINERAL RESOURCES; MINERALOGY; NUCLEAR MEDICINE; OPTICAL IMAGE STORAGE; RATING; TISSUE; TOMOGRAPHY;

INFRARED DEVICES;

2 DEOXYINOSOSE; 2-DEOXYINOSOSE; BISPHOSPHONIC ACID DERIVATIVE; DIAGNOSTIC AGENT; DRUG DERIVATIVE; INOSITOL; MEDRONATE TECHNETIUM TC 99M; PAMIDRONIC ACID; RADIOPHARMACEUTICAL AGENT; TECHNETIUM TC 99M HYDROXYMETHYLENE DIPHOSPHONATE;

ANIMAL; ARTICLE; BONE MINERALIZATION; BONE TUMOR; FEASIBILITY STUDY; HAIRLESS MOUSE; METHODOLOGY; MOUSE; NEAR INFRARED SPECTROSCOPY; OSTEOSARCOMA; PATHOLOGY; PATHOPHYSIOLOGY; PHYSIOLOGY; XENOGRAFT;

ANIMALS; BONE NEOPLASMS; CALCIFICATION, PHYSIOLOGIC; DIPHOSPHONATES; FEASIBILITY STUDIES; INOSITOL; MICE; MICE, HAIRLESS; OSTEOSARCOMA; RADIOPHARMACEUTICALS; SPECTROSCOPY, NEAR-INFRARED; TECHNETIUM TC 99M MEDRONATE; TRANSPLANTATION, HETEROLOGOUS;

EID: 83155168197     PISSN: 02841851     EISSN: 16000455     Source Type: Journal    
DOI: 10.1258/ar.2011.110131     Document Type: Article

References (19)

1. Zaheer A, Lenkinski RE, Mahmood A, et al. In vivo near-infrared fluorescence imaging of osteoblastic activity. Nature Biotechnol 2001;19:1148-54 (Pubitemid 33115701)
2. Kovar JL, Volcheck W, Sevick-Muraca E, et al. Characterization and performance of a near-infrared 2-deoxyglucose optical imaging agent for mouse cancer models. Anal Biochem 2009;384:254-62
3. Mayer-Kuckuk P, Boskey AL. Molecular imaging promotes progress in orthopedic research. Bone 2006;39:965-77 (Pubitemid 44528381)
4. Nakayama H, Kawase T, Kogami H, et al. Evaluation by bone scintigraphy of osteogenic activity of commercial bioceramics (porous b-TCP and HAp particles) subcutaneously implanted in rats. J Biomater Appl 2010;24:751-68
5. Takahashi K, Akiyama Y, Kanazawa H, et al. Establishment and biological studies of rat osteosarcoma cell line (MSK). J Jpn StomatolSoc 1989;38:870-88 (in Japanese)
6. Cheng Z, Levi J, Xiong Z, et al. Near-infrared fluorescent deoxyglucose analogue for tumor optical imaging in cell culture and living mice. Bioconj Chem 2006;17:662-9 (Pubitemid 43794375)
7. Nancollas GH, Tang R, Phipps RJ, et al. Novel insights into actions of bisphosphonates on bone: differences in interactions with hydroxyapatite. Bone 2006;38:617-27
8. Kawase T, Okuda K, Kogami H, et al. Human periosteum-derived cells combined with superporous hydroxyapatite blocks used as an osteogenic bone substitute for periodontal regenerative therapy: An animal implantation study using nude mice. J Periodontol 2010;81:420-7
9. See http://www.licor.com/bio/products/imaging-systems/pearl/pearl- sensitivity.jsp (last checked December 21, 2010)
10. Kawase T, Okuda K, Kogami H, et al. Characterization of human cultured periosteal sheets expressing bone-forming potential: in vitro and in vivo animal studies. J Tissue Eng Regen Med 2009;3:218-29
11. Zhou H, Luby-Phelps K, Mickey BE, et al. Dynamic near-infrared optical imaging of 2-deoxyglucose uptake by intracranial glioma of athymic mice. PLoS One 2009;4:e8051
12. Dearling JL, Flynn AA, Sutcliffe-Goulden J, et al. Analysis of the regional uptake of radiolabeled deoxyglucose analogs in human tumor xenografts. J NuclMed 2004;45:101-7 (Pubitemid 47611615)
13. Snoeks TJ, Khmelinskii A, Lelieveldt BP, et al. Optical advances in skeletal imaging applied to bone metastases. Bone 2011;48:106-14
14. Kubota K. From tumor biology to clinical PET: a review of positron emission tomography (PET) in oncology. Ann Nucl Med 2001;15:471-86 (Pubitemid 34131944)
15. Fleisch H. Bisphosphonates: mechanisms of action. Endocrine Rev 1998;19:80-100 (Pubitemid 29122075)
16. Henneman ZJ, Nancollas GH, Ebetino FH, et al. Bisphosphonate binding affinity as assessed by inhibition of carbonated apatite dissolution in vitro. J Biomed Mater Res A 2008;85:993-1000 (Pubitemid 351717968)
17. Fontana A, Delmas PD. Markers of bone turnover in bone metastases. Cancer 2000;88(Suppl. 12): 2952):2952-60 (Pubitemid 30413178)
18. Kozloff KM, Weissleder R, Mahmood U. Noninvasive optical detection of bone mineral. J Bone Miner Res 2007;22:1208-16 (Pubitemid 351339703)
19. Aikawa E, Nahrendorf M, Figueiredo JL, et al. Osteogenesis associates with inflammation in early-stage atherosclerosis evaluated by molecular imaging in vivo. Circulation 2007;116:2841-50 (Pubitemid 350301146)